Valid for Submission
C84.7A is a billable diagnosis code used to specify a medical diagnosis of anaplastic large cell lymphoma, alk-negative, breast. The code C84.7A is valid during the fiscal year 2022 from October 01, 2021 through September 30, 2022 for the submission of HIPAA-covered transactions.
New 2022 ICD-10 Code
C84.7A is new to ICD-10 code set for the FY 2022, effective October 1, 2021. The National Center for Health Statistics (NCHS) has published an update to the ICD-10-CM diagnosis codes which became effective October 1, 2021. This is a new and revised code for the FY 2022 (October 1, 2021 - September 30, 2022).
Tabular List of Diseases and Injuries
The Tabular List of Diseases and Injuries is a list of ICD-10 codes, organized "head to toe" into chapters and sections with coding notes and guidance for inclusions, exclusions, descriptions and more. The following references are applicable to the code C84.7A:
Inclusion TermsInclusion Terms
These terms are the conditions for which that code is to be used. The terms may be synonyms of the code title, or, in the case of "other specified" codes, the terms are a list of the various conditions assigned to that code. The inclusion terms are not necessarily exhaustive. Additional terms found only in the Alphabetic Index may also be assigned to a code.
- Breast implant associated anaplastic large cell lymphoma (BIA-ALCL)
Use Additional CodeUse Additional Code
The “use additional code” indicates that a secondary code could be used to further specify the patient’s condition. This note is not mandatory and is only used if enough information is available to assign an additional code.
Index to Diseases and Injuries
The Index to Diseases and Injuries is an alphabetical listing of medical terms, with each term mapped to one or more ICD-10 code(s). The following references for the code C84.7A are found in the index:
Diagnostic Related Groups - MS-DRG Mapping
|MS-DRG||MS-DRG Title||MCD||Relative Weight|
|820||LYMPHOMA AND LEUKEMIA WITH MAJOR O.R. PROCEDURES WITH MCC||17||5.6873|
|821||LYMPHOMA AND LEUKEMIA WITH MAJOR O.R. PROCEDURES WITH CC||17||2.1551|
|822||LYMPHOMA AND LEUKEMIA WITH MAJOR O.R. PROCEDURES WITHOUT CC/MCC||17||1.2516|
The relative weight of a diagnostic related group determines the reimbursement rate based on the severity of a patient's illness and the associated cost of care during hospitalization.
C847A replaces the following previously assigned ICD-10 code(s):